1.50
price down icon3.23%   -0.05
 
loading
Schlusskurs vom Vortag:
$1.55
Offen:
$1.55
24-Stunden-Volumen:
8,763
Relative Volume:
0.54
Marktkapitalisierung:
$45.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.5953
EPS:
-2.5197
Netto-Cashflow:
-
1W Leistung:
-0.66%
1M Leistung:
+7.14%
6M Leistung:
-26.83%
1J Leistung:
-57.51%
1-Tages-Spanne:
Value
$1.47
$1.55
1-Wochen-Bereich:
Value
$1.50
$1.5506
52-Wochen-Spanne:
Value
$1.10
$3.89

Adlai Nortye Ltd Adr Stock (ANL) Company Profile

Name
Firmenname
Adlai Nortye Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
123
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ANL's Discussions on Twitter

Vergleichen Sie ANL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ANL
Adlai Nortye Ltd Adr
1.47 57.93M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.26 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.08 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.43 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.02 29.19B 3.81B -644.79M -669.77M -6.24

Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Herabstufung H.C. Wainwright Buy → Neutral
2024-09-04 Eingeleitet H.C. Wainwright Buy
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight

Adlai Nortye Ltd Adr Aktie (ANL) Neueste Nachrichten

pulisher
Jul 09, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Jul 09, 2025
pulisher
Jul 09, 2025

Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes - TipRanks

Jul 09, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jun 27, 2025

Adlai Nortye (NASDAQ:ANL) Trading Down 5.5% – Here’s What Happened - Defense World

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Capricor Therapeutics (CAPR) and Abbott Laboratories (ABT) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS - Investing.com

Jun 02, 2025
pulisher
May 30, 2025

Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks

May 30, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India

Apr 07, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India

Mar 28, 2025
pulisher
Feb 14, 2025

Adlai Nortye Announces Change in Auditing Firm - TipRanks

Feb 14, 2025
pulisher
Dec 31, 2024

Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks

Dec 31, 2024
pulisher
Oct 18, 2024

Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com India

Oct 18, 2024
pulisher
Sep 29, 2023

Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive

Sep 29, 2023
pulisher
Sep 27, 2023

Adlai Nortye Announces 2.5M ADS IPO at $23/sh - Investing.com

Sep 27, 2023
pulisher
Aug 17, 2023

CRVO Stock Quote Price and Forecast - CNN

Aug 17, 2023

Finanzdaten der Adlai Nortye Ltd Adr-Aktie (ANL)

Es liegen keine Finanzdaten für Adlai Nortye Ltd Adr (ANL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.82
price up icon 4.72%
$36.03
price down icon 0.23%
$103.28
price up icon 0.29%
$28.13
price up icon 5.39%
$113.83
price up icon 2.13%
biotechnology ONC
$294.35
price down icon 0.43%
Kapitalisierung:     |  Volumen (24h):